Levosulpiride-induced parkinsonism in a young adult: A case report

Authors

DOI:

https://doi.org/10.22516/25007440.1519

Keywords:

Dyspepsia, parkinsonism, extrapyramidal disorders, drug-related side effects and adverse reactions, pharmacovigilance, case reports

Abstract

Background: Levosulpiride is a selective dopamine D2 receptor antagonist with prokinetic activity that is widely used in the management of functional dyspepsia and other gastrointestinal motility disorders. Although its action is considered predominantly peripheral, its affinity for central dopaminergic receptors may be associated with neurologic adverse effects.

Case Report: The case of a young patient who developed severe extrapyramidal symptoms consistent with parkinsonism after receiving therapeutic doses of levosulpiride for 10 days is presented. Causality assessment using the Naranjo scale indicated a probable relationship between drug exposure and the adverse event, and a diagnosis of drug-induced parkinsonism was established. Treatment with biperiden was required, followed by progressive resolution of symptoms.

Conclusions: This case highlights that levosulpiride, despite its widespread use in gastroenterology and generally favorable safety profile, may induce drug-induced parkinsonism even in young patients without identifiable risk factors following short-term exposure at standard doses. This underscores the importance of pharmacovigilance and early recognition of neurologic adverse effects in clinical practice.

Downloads

Download data is not yet available.

Author Biographies

German Vicioso Álvarez, Empresa Social del Estado Universitaria del Atlántico

Médico, especialista en Medicina Interna, especialista en Educación para Profesionales de la Salud, Empresa Social del Estado Universitaria del Atlántico. Grupo de Investigación Clínica y Asistencial, Fundación Universitaria San Martín. Barranquilla, Colombia.

Shaden Michelle Comas Salgado2, Universidad Simón Bolívar

Estudiante de Pregrado en Medicina. Grupo de Investigación Clínica y Asistencial, Universidad Simón Bolívar. Barranquilla, Colombia.

Laura Sofía García Sánchez, Universidad Simón Bolívar

Estudiante de Pregrado en Medicina. Grupo de Investigación Clínica y Asistencial, Universidad Simón Bolívar. Barranquilla, Colombia.

Samara Villamizar Tobías, Universidad Metropolitana

Estudiante de Medicina, Universidad Metropolitana. Grupo de Investigación Clínica y Asistencial (GICA). Barranquilla, Colombia.

References

Serra J. Levosulpirida en el manejo de la dispepsia funcional y la gastroparesia. Gastroenterol Hepatol. 2010;33(8):586-90. https://doi.org/10.1016/j.gastrohep.2010.07.002

Tonini M, Cipollina L, Poluzzi E, Crema F, Corazza GR, De Ponti F. Review article: Clinical implications of enteric and central D2 receptor blockade by antidopaminergic gastrointestinal prokinetics. Aliment Pharmacol Ther. 2004;19(4):379-90. https://doi.org/10.1111/j.1365-2036.2004.01867.x

Gowtham A, Sulthana B, Sacheendran D, Ovallath S. Levosulpiride induced parkinsonism and other movement disorders. Open Access J Neurol Neurosurg. 2017;5(3):42-6. https://doi.org/10.19080/OAJNN.2017.05.555665

Margolese HC, Chouinard G, Kolivakis TT, Beauclair L, Miller R. Tardive dyskinesia in the era of typical and atypical antipsychotics. Part 1: Pathophysiology and mechanisms of induction. Can J Psychiatry. 2005;50:541-47. https://doi.org/10.1177/070674370505000907

Shin HW, Chung SJ. Drug-induced parkinsonism. J Clin Neurol. 2012;8(1):15-21. https://doi.org/10.3988/jcn.2012.8.1.15

Miller LG, Jankovic J. Neurologic approach to drug-induced movement disorders: a study of 125 patients. South Med J. 1990;83(5):525-32. https://doi.org/10.1097/00007611-199005000-00011

Thanvi B, Treadwell J. Drug-induced parkinsonism: a common cause of parkinsonism in older people. Postgrad Med J. 2009;85(1004):322-26. https://doi.org/10.1136/pgmj.2008.073312

Mathew T, Nadimpally US, Prabhu AD, Nadig R. Drug-induced parkinsonism on the rise: beware of levosulpiride and its combinations with proton pump inhibitors. Neurol India. 2017;65(1):173-74. https://doi.org/10.4103/0028-3886.198175

Joe J. Levosulpiride-induced neurological adverse effects: a prospective study from a tertiary care center. Ann Indian Acad Neurol. 2020;23(2):174-76. https://doi.org/10.4103/aian.AIAN_449_18

Montastruc JL, Llau ME, Rascol O, Senard JM. Drug-induced parkinsonism: a review. Fundam Clin Pharmacol. 1994;8(4):293-306. https://doi.org/10.1111/j.1472-8206.1994.tb00808.x

Shin HW, Kim MJ, Kim JS, Lee MC, Chung S. Levosulpiride-induced movement disorders. Mov Disord. 2009;24(15):2249-53. https://doi.org/10.1002/mds.22805

Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239-45. https://doi.org/10.1038/clpt.1981.154

López-Sendón JL, Mena MA, de Yébenes JG. Drug-induced parkinsonism in the elderly: incidence, management and prevention. Drugs Aging. 2012;29(2):105-118. https://doi.org/10.2165/11598540-000000000-00000

Choudhury S, Chatterjee K, Singh R, Shubham S, Trivedi S, Chatterjee S, et al. Levosulpiride-induced movement disorders: Indian scenario. J Pharmacol Pharmacother. 2017;8(4):177-81. https://doi.org/10.4103/jpp.JPP_32_17

Vaiman EE, Shnayder NA, Khasanova AK, Strelnik AI, Gayduk AJ, Al-Zamil M, et al. Pathophysiological mechanisms of antipsychotic-induced parkinsonism. Biomedicines. 2022;10(8):2010. https://doi.org/10.3390/biomedicines10082010

Tandon VR, Ismail SH, Singh A. Fixed drug combination (levosulpiride and rabeprazole)-induced atypical parkinsonian disorders with associated anxiety and low-lying depression. Indian J Pharmacol. 2024;56(1):52-4. https://doi.org/10.4103/ijp.ijp_929_21

Conn H, Jankovic J. Drug-induced parkinsonism: diagnosis and treatment. Expert Opin Drug Saf. 2024;23(12):1503-13. https://doi.org/10.1080/14740338.2024.2418950

Mathews M, Gratz S, Adetunji B, George V, Mathews M, Basil B. Antipsychotic-induced movement disorders: evaluation and treatment. Psychiatry (Edgmont). 2005;2(3):36-41.

Instituto Nacional de Vigilancia de Medicamentos y Alimentos. Resolución 2024015321 del 8 de abril de 2024. Por la cual se establece el reglamento relativo al contenido y periodicidad de los reportes de eventos adversos y los programas de farmacovigilancia para titulares de registro sanitario y fabricantes. Bogotá: INVIMA; 2024.

Figura 1. Tomografía computarizada de cráneo simple sin hallazgos patológicos. Imagen propiedad de los autores.

Published

2026-11-13

How to Cite

Vicioso Álvarez, G., Comas Salgado2, S. M., García Sánchez, L. S., & Villamizar Tobías, S. (2026). Levosulpiride-induced parkinsonism in a young adult: A case report. Revista Colombiana De Gastroenterología, 41(4), 508–513. https://doi.org/10.22516/25007440.1519

Altmetric

Escanea para compartir
QR Code
Crossref Cited-by logo
Article metrics
Abstract views1
Galley views0
PDF Views0
HTML views0
Other views0